Clinical Trial Update: Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of lansoprazole 30 mg twice daily for laryngitis associated with gastroesophageal reflux. The study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Laryngitis
• Laryngopharyngeal Reflux

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: American Institute for Voice and Ear Research | Conditions: Laryngopharyngeal Reflux | Phase 4 | Status: TERMINATED | Results posted: 2012-08-17